Recruiting Follicular Lymphoma Studies in Irvine
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a p...
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
The purpose of this multicenter, randomized, placebo-controlled and double-blind study is to evaluate the efficacy and safety of subcutaneous anifrolumab compared with placebo on the overall disease a...
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
This phase II trial tests how well mosunetuzumab and polatuzumab vedotin works in treating patients with grade 1-3a follicular lymphoma that has come back after a period of improvement (relapsed) or t...
Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
This phase II trial tests the safety, side effects and effectiveness of epcoritamab and tazemetostat in treating patients with grade I-IIIa follicular lymphoma that has come back after a period of imp...
Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma
This phase II trial tests how well lenalidomide and epcoritamab works in treating patients with follicular lymphoma that has not been previously treated. Although follicular lymphoma is incurable, pro...
About Follicular Lymphoma Clinical Trials in Irvine
Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.
There are currently 5 follicular lymphoma clinical trials recruiting participants in Irvine, CALIFORNIA. These studies are seeking a combined 941 participants. Research is being sponsored by National Cancer Institute (NCI), AstraZeneca, City of Hope Medical Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Follicular Lymphoma Clinical Trials in Irvine — FAQ
Are there follicular lymphoma clinical trials in Irvine?
Yes, there are 5 follicular lymphoma clinical trials currently recruiting in Irvine, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Irvine?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Irvine research site will contact you about next steps.
Are clinical trials in Irvine free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Irvine studies also compensate for your time and travel.
What follicular lymphoma treatments are being tested?
The 5 active trials in Irvine are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov